Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Learn about cardiac myosin inhibitors as a treatment option for hypertrophic cardiomyopathy (HCM) in this 21-minute medical symposium presentation. Explore the mechanism of action, clinical applications, and therapeutic benefits of these innovative medications that target the underlying molecular pathophysiology of HCM. Discover how cardiac myosin inhibitors work to reduce left ventricular outflow tract obstruction and improve symptoms in patients with obstructive HCM. Gain insights into patient selection criteria, dosing considerations, monitoring requirements, and potential side effects of this emerging therapeutic class. Understand the clinical trial data supporting the use of these medications and their role in the comprehensive management of HCM patients. Access expert knowledge from Johns Hopkins Medicine's cardiology specialists to better understand this advancing treatment modality for hypertrophic cardiomyopathy.
